Pediatric intestinal failure

CP Duggan, T Jaksic - New England Journal of Medicine, 2017 - Mass Medical Soc
Pediatric Intestinal Failure | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Incidence, prevention, and treatment of parenteral nutrition–associated cholestasis and intestinal failure–associated liver disease in infants and children: a systematic …

G Lauriti, A Zani, R Aufieri, M Cananzi… - Journal of parenteral …, 2014 - Wiley Online Library
Background: Cholestasis is a significant life‐threatening complication in children on
parenteral nutrition (PN). Strategies to prevent/treat PN‐associated cholestasis (PNAC) and …

When is parenteral nutrition appropriate?

P Worthington, J Balint, M Bechtold… - Journal of Parenteral …, 2017 - Wiley Online Library
Parenteral nutrition (PN) represents one of the most notable achievements of modern
medicine, serving as a therapeutic modality for all age groups across the healthcare …

Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome

RJ Merritt, V Cohran, BP Raphael… - Journal of pediatric …, 2017 - journals.lww.com
Intestinal failure is a rare, debilitating condition that presents both acute and chronic medical
management challenges. The condition is incompatible with life in the absence of the safe …

ASPEN definitions in pediatric intestinal failure

BP Modi, DP Galloway, K Gura, A Nucci… - Journal of Parenteral …, 2022 - Wiley Online Library
Pediatric intestinal failure (PIF) is a relatively rare disease entity that requires focused
interdisciplinary care and specialized nutrition management. There has long been a lack of …

Guidelines for parenteral nutrition in preterm infants: The American Society for Parenteral and Enteral Nutrition

DT Robinson, KL Calkins, Y Chen… - Journal of Parenteral …, 2023 - Wiley Online Library
Background Parenteral nutrition (PN) is prescribed for preterm infants until nutrition needs
are met via the enteral route, but unanswered questions remain regarding PN best practices …

Neonatal cholestasis

AG Feldman, RJ Sokol - Neoreviews, 2013 - publications.aap.org
Cholestatic jaundice is a common presenting feature of neonatal hepatobiliary and
metabolic dysfunction. Any infant who remains jaundiced beyond age 2 to 3 weeks should …

Phytosterols promote liver injury and Kupffer cell activation in parenteral nutrition–associated liver disease

KC El Kasmi, AL Anderson, MW Devereaux… - Science translational …, 2013 - science.org
Parenteral nutrition–associated liver disease (PNALD) is a serious complication of PN in
infants who do not tolerate enteral feedings, especially those with acquired or congenital …

Lipids in the intensive care unit: recommendations from the ESPEN Expert Group

PC Calder, M Adolph, NE Deutz, T Grau, JK Innes… - Clinical Nutrition, 2018 - Elsevier
This article summarizes the presentations given at an ESPEN Workshop on “Lipids in the
ICU” held in Tel Aviv, Israel in November 2014 and subsequent discussions and updates …

Intestinal failure–associated liver disease: a position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation

F Lacaille, G Gupte, V Colomb, L D'Antiga… - Journal of pediatric …, 2015 - journals.lww.com
Intestinal failure–associated liver disease is the most prevalent complication affecting
children with intestinal failure receiving long-term parenteral nutrition. This paper reviews …